Nanomedicines: Targeting inflammatory pathway in cancer and aging

Olga A. Sukocheva, Yonggang Zhang

Research output: Contribution to journalEditorial


Nanomedicine is a novel, highly blended stream of medicine founded on nanoscience, medical nanotechnology, pharmaceutical sciences, biological chemistry, life sciences, and cutting-edge molecular medicine. Nanomedicine aims to fight human diseases, solve current problems associated with the disease diagnostics, personalized therapy, and monitoring of the patient progress to recovery using current discoveries in nanoscience. Application of various polymeric, metal- and liposome-based nanoparticles in health care opens anticipated opportunity for development of novel therapies for cancer, inflammation-related pathologies, metabolic abnormalities, neurological and cardiological problems in the aging population [1], [2], [3]. Considering the unique structural design of nanoparticles, nanomedicine represents a desirable tool in early diagnostics and treatment of majority of cancers, including the most advanced, later-stage malignancies in patients with existing pro-inflammatory conditions, metabolic anomalies, and other chronic pathologies associated with aging [4], [5], [6], [7].
Original languageEnglish
Pages (from-to)1218-1221
Number of pages4
Issue numberPart 2
Early online date28 Oct 2022
Publication statusPublished - Nov 2022


  • Nanomedicines
  • Cancer
  • Ageing
  • Inflammatory pathway


Dive into the research topics of 'Nanomedicines: Targeting inflammatory pathway in cancer and aging'. Together they form a unique fingerprint.

Cite this